STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: A pilot study

Journal of Leukocyte Biology

Volumn 97, Issue 4, 2015, Pages 791-796

  Demaret, Julie ^a,b   Dupont, Guillaume ^a,c   Venet, Fabienne ^a,b   Friggeri, Arnaud ^d   Lepape, Alain ^d   Rimmelé, Thomas ^a   Morel, Jérôme ^c   Monneret, Guillaume ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Immunosuppression; Sepsis; Septic shock

Indexed keywords

CD4 ANTIGEN; RECOMBINANT INTERLEUKIN 7; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL7 PROTEIN, HUMAN; INTERLEUKIN 7; RECOMBINANT PROTEIN; VASOCONSTRICTOR AGENT;

AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL SURVIVAL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; LYMPHOCYTOPENIA; MALE; MORTALITY; PATIENT MONITORING; PILOT STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SEPSIS; SEPTIC SHOCK; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TREATMENT RESPONSE; BLOOD; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; FOLLOW UP; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MULTIPLE ORGAN FAILURE; PHOSPHORYLATION; PROTEIN PROCESSING; SHOCK, SEPTIC; SURVIVAL;

AGED; BIOLOGICAL MARKERS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOCOMPROMISED HOST; IN VITRO TECHNIQUES; INTERLEUKIN-7; MALE; MULTIPLE ORGAN FAILURE; PHOSPHORYLATION; PILOT PROJECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SHOCK, SEPTIC; STAT5 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; VASOCONSTRICTOR AGENTS;

EID: 84929206746     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5AB1114-545R     Document Type: Article

References (23)

1. Angus, D. C., van der Poll, T. (2013) Severe sepsis and septic shock. N. Engl. J. Med. 369, 840–851.
2. Levy, M. M., Artigas, A., Phillips, G. S., Rhodes, A., Beale, R., Osborn, T., Vincent, J. L., Townsend, S., Lemeshow, S., Dellinger, R. P. (2012) Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect. Dis. 12, 919–924.
3. Hotchkiss, R. S., Monneret, G., Payen, D. (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862–874.
4. Rochman, Y., Spolski, R., Leonard, W. J. (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat. Rev. Immunol. 9, 480–490.
5. Lévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., Rouzioux, C., Avettand-Fenoël, V., Croughs, T., Beq, S., Morre, M., Poulin, J. F., Sekaly, R. P., Thiebaut, R., Lederman, M. M. (2012) Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study. Clin. Infect. Dis. 55, 291–300.
6. Mackall, C. L., Fry, T. J., Gress, R. E. (2011) Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol. 11, 330–342.
7. Sportès, C., Babb, R. R., Krumlauf, M. C., Hakim, F. T., Steinberg, S. M., Chow, C. K., Brown, M. R., Fleisher, T. A., Noel, P., Maric, I., Stetler-Stevenson, M., Engel, J., Buffet, R., Morre, M., Amato, R. J., Pecora, A., Mackall, C. L., Gress, R. E. (2010) Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin. Cancer Res. 16, 727–735.
8. Hotchkiss, R. S., Moldawer, L. L. (2014) Parallels between cancer and infectious disease. N. Engl. J. Med. 371, 380–383.
9. Venet, F., Foray, A. P., Villars-Méchin, A., Malcus, C., Poitevin-Later, F., Lepape, A., Monneret, G. (2012) IL-7 restores lymphocyte functions in septic patients. J. Immunol. 189, 5073–5081.
10. Unsinger, J., Burnham, C. A., McDonough, J., Morre, M., Prakash, P. S., Caldwell, C. C., Dunne, Jr., W. M., Hotchkiss, R. S. (2012) Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J. Infect. Dis. 206, 606–616.
11. Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., Morre, M., Hildeman, D. A., Caldwell, C. C., Hotchkiss, R. S. (2010) IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184, 3768–3779.
12. Venet, F., Chung, C. S., Kherouf, H., Geeraert, A., Malcus, C., Poitevin, F., Bohé, J., Lepape, A., Ayala, A., Monneret, G. (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (2)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 35, 678–686.
13. Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., Osborn, T. M., Nunnally, M. E., Townsend, S. R., Reinhart, K., Kleinpell, R. M., Angus, D. C., Deutschman, C. S., Machado, F. R., Rubenfeld, G. D., Webb, S. A., Beale, R. J., Vincent, J. L., Moreno, R.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41, 580–637.
14. Venet, F., Lukaszewicz, A. C., Payen, D., Hotchkiss, R., Monneret, G. (2013) Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr. Opin. Immunol. 25, 477–483.
15. Dupont, G., Demaret, J., Venet, F., Malergue, F., Malcus, C., Poitevin-Later, F., Morel, J., Monneret, G. (2014) Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP32 cells versus regulatory T cells: a whole blood perspective. Cytokine 69, 146–149.
16. Hotchkiss, R. S., Coopersmith, C. M., McDunn, J. E., Ferguson, T. A. (2009) The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15, 496–497.
17. Hotchkiss, R. S., Opal, S. (2010) Immunotherapy for sepsis—a new approach against an ancient foe. N. Engl. J. Med. 363, 87–89.
18. Hotchkiss, R. S., Monneret, G., Payen, D. (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect. Dis. 13, 260–268.
19. Alpdogan, O., van den Brink, M. R. (2005) IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 26, 56–64.
20. Morre, M., Beq, S. (2012) Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival. Target Oncol. 7, 55–68.
21. Kühlhorn, F., Rath, M., Schmoeckel, K., Cziupka, K., Nguyen, H. H., Hildebrandt, P., Hünig, T., Sparwasser, T., Huehn, J., Pötschke, C., Bröker, B. M. (2013) Foxp3+ regulatory T cells are required for recovery from severe sepsis. PLoS ONE 8, e65109.
22. Scumpia, P. O., Delano, M. J., Kelly, K. M., O’Malley, K. A., Efron, P. A., McAuliffe, P. F., Brusko, T., Ungaro, R., Barker, T., Wynn, J. L., Atkinson, M. A., Reeves, W. H., Salzler, M. J., Moldawer, L. L. (2006) Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J. Immunol. 177, 7943–7949.
23. Xiao, W., Mindrinos, M. N., Seok, J., Cuschieri, J., Cuenca, A. G., Gao, H., Hayden, D. L., Hennessy, L., Moore, E. E., Minei, J. P., Bankey, P. E., Johnson, J. L., Sperry, J., Nathens, A. B., Billiar, T. R., West, M. A., Brownstein, B. H., Mason, P. H., Baker, H. V., Finnerty, C. C., Jeschke, M. G., López, M. C., Klein, M. B., Gamelli, R. L., Gibran, N. S., Arnoldo, B., Xu, W., Zhang, Y., Calvano, S. E., McDonald-Smith, G. P., Schoenfeld, D. A., Storey, J. D., Cobb, J. P., Warren, H. S., Moldawer, L. L., Herndon, D. N., Lowry, S. F., Maier, R. V., Davis, R. W., Tompkins, R. G.; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program. (2011) A genomic storm in critically injured humans. J. Exp. Med. 208, 2581–2590.